ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01725269
Recruitment Status : Terminated (Terminated early dt acquisition of Sponsor and change in corporate priorities)
First Posted : November 12, 2012
Last Update Posted : April 9, 2014
Sponsor:
Information provided by (Responsible Party):
Aires Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : April 2014
Publications:
Hassoun, PM. Pulmonary arterial hypertension complicating connective tissue disease. In: Humbert M., Lynch JP, Eds. Pulmonary Hypertension. New York: Informa Healthcare USA, Inc. 2010: 161-175.
Levi, DS, Scott, V, Aboulhosn J. Pulmonary arterial hypertension in congenital heart disease. In: Humbert, M, Lynch, JP, Eds. Pulmonary Hypertension. New York: Informa Healthcare USA, Inc. 2010: 176-195.
Ware, JE et al. How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: QualityMetric, Incorporated, 2000.